Physician profile
Daniel C Schiffner
NPI 1972791671
$6,559.91
in general payments reported to CMS, 2019-2025
13 companies · $763 in 2025
The $763 reported for 2025 was more than what 80% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,837 · 2020: $43.33 · 2021: $83.70 · 2022: $253 · 2023: $790 · 2024: $789 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,342.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $3,323.79 | 2019 | |
| Siemens Medical Solutions USA, INC. | $1,536.47 | 2022-2025 | Truebeam, Varian Treatment, Varian Ethos Treatment Planning |
| Brainlab, INC. | $539.30 | 2019-2025 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning, Image Guided Surgical Device, Brainlab, INC. |
| Novocure INC. | $327.80 | 2019-2025 | Optune, Optune Gio |
| Boston Scientific Corporation | $292.81 | 2021-2025 | Spaceoar System, Spaceoar Vue System - 10ml |
| Zap Surgical Systems, INC. | $154.05 | 2023 | Zap-X Radiosurgery System, Zap-X Treatment Planning Software, Zap-X Mv Imager |
| Hologic INC | $125.00 | 2019 | |
| Focal Therapeutics, INC. | $108.04 | 2019 | |
| Elekta, INC. | $50.00 | 2021 | |
| Sumitomo Pharma America, INC. | $35.60 | 2025 | Orgovyx |
| Gt Medical Technologies, INC | $31.19 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.78 | 2019 | |
| Varian Medical Systems, INC. | $12.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Schiffner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.